Washington University Career Development Program in Drug Abuse and Addiction

华盛顿大学药物滥用和成瘾职业发展计划

• 批准号: 9917745
• 负责人: Laura J. Bierut
• 金额: $ 43.38万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-05-01 至 2022-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9917745
• 关键词: Address; Advisory Committees; Basic Science; Clinical Research; Complement; Complex; Development; Development Plans; Diagnostic; Discipline; Drug Addiction; Drug abuse; Evaluation; Faculty; Funding; Genetic; Genetic Research; Goals; Grant; Health; Health Sciences; Human; Individual; Institution; Interview; Master of Science; Mentored Clinical Scientist Development Program; Mentors; Mentorship; Methodology; National Institute of Drug Abuse; Positioning Attribute; Postdoctoral Fellow; Program Development; Research; Research Personnel; Research Training; Science; Science of genetics; Scientist; Study Section; Surveys; System; Teacher Professional Development; Therapeutic; Training; Training Programs; Translational Research; Universities; Washington; Work; Writing; addiction; career development; clinical investigation; design; interdisciplinary approach; interest; medical schools; multidisciplinary; next generation; population health; programs; recruit; research and development; translational genetics

Abstract The goal of this K12 program is to support and train the next generation of clinician scientists with expertise in the genetics of drug abuse and addiction. Drug abuse research is becoming increasingly complex and multidisciplinary. Approaches from single disciplines have done much to advance science, and methodological and technological advances in genetics have established the need for increasingly multidisciplinary approaches to address complex questions about addiction and genetics in human health. Bringing this potential of basic science genetic discovery to advance drug abuse and addiction research requires clinician scientists who can make important diagnostic and therapeutic advances through translational genetics research. To accomplish the goals of this program, we have established the following specific aims: 1. Create 2 new scholar faculty positions at Washington University School of Medicine (WUSM) and support scholars focused on drug abuse and addiction genetic research. The first scholar will begin in Year 1 of the program. The second scholar will be recruited in Year 3 of the program. 2. Develop scholar-specific didactic training programs designed to complement each scholar’s individual needs and interests. The didactic training will make use of existing coursework and seminars offered across WU, with most courses centered around two outstanding post-doctoral research training programs: the Master of Science in Clinical Investigation and the Master of Population Health Sciences. 3. Provide short-term and long-term research mentorship for scholars through formal mentoring relationships with diverse faculty. 4. Design scholar specific career development plans that will include a focus on the critical transitional step to independent funding. This training will be accomplished through grant writing courses, mock study sections, and mentoring. 5. Establish a comprehensive system to evaluate the WU NIDA K12 Program. We will evaluate the scholars, mentors, faculty and training programs using surveys, interviews, and other metrics. Scholar career development will be tracked long-term, and an independent, annual evaluation will be conducted by the program Advisory Committee. The WU NIDA K12 Program will enable us to take advantage of existing and highly successful clinical and translational research training programs to promote career development and research of 2 clinician scientists whose work focuses on drug abuse and addiction and genetics. This program will support the development of researchers who can compete for faculty positions at the best institutions in the world and produce a body of work to substantially advance our understanding of drug abuse and addiction.

摘要 该K12计划的目标是支持和培训下一代临床科学家，他们具有以下方面的专业知识： 药物滥用和成瘾的遗传学药物滥用研究正变得越来越复杂， 多学科的。来自单一学科的方法对推进科学和方法论做出了很大贡献。 遗传学的技术进步已经建立了越来越多的多学科的需求 解决人类健康中成瘾和遗传学等复杂问题的方法。提起这个 基础科学基因发现的潜力，以促进药物滥用和成瘾研究需要临床医生 科学家们可以通过转译遗传学做出重要的诊断和治疗进展， research.为实现该计划的目标，我们制定了以下具体目标： 1.在华盛顿大学医学院（WUSM）设立2个新的学者教师职位， 支持专注于药物滥用和成瘾遗传研究的学者。第一位学者将开始在 项目的第一年。第二位学者将在该计划的第三年招募。 2.制定针对每个学者的教学培训计划，以补充每个学者的个人 需要和兴趣。教学培训将利用现有的课程和提供的研讨会 在整个吴，与围绕两个优秀的博士后研究培训大部分课程 计划：科学在临床调查和人口健康科学硕士硕士。 3.通过正式的导师制为学者提供短期和长期的研究导师制 与不同教师的关系。 4.设计学者具体的职业发展计划，将包括对关键的过渡重点 走向独立融资。这项培训将通过赠款写作课程，模拟 学习小组和辅导 5.建立一个全面的系统来评估吴尼达K12计划。我们将评估 使用调查、访谈和其他指标的学者、导师、教师和培训计划。学者 将长期跟踪职业发展，并进行独立的年度评估 由项目咨询委员会。 WU NIDA K12计划将使我们能够利用现有的和非常成功的临床和 转化研究培训计划，以促进2名临床科学家的职业发展和研究 他的工作重点是药物滥用、成瘾和遗传学。该计划将支持开发 研究人员谁可以在世界上最好的机构竞争教师职位，并产生一个机构， 努力大幅提高我们对药物滥用和成瘾的认识。